Healthcare & Life Sciences
Lysosomal Therapeutics, Inc.
United States
Lysosomal Therapeutics, Inc. is a startup based in the United States, most recent round Series A, 1 tracked investor.
series-a
series-a
Stage
1
Investors
About Lysosomal Therapeutics, Inc.
Based in the United States, Lysosomal Therapeutics, Inc. is a startup. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Lysosomal Therapeutics, Inc. is a biotechnology company focused on developing therapies that target lysosomal biology to treat lysosomal and related diseases.
Explore Lysosomal Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.